PIDTC: Investigating Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with P47phox Chronic Granulomatous Disease
Apr 24, 2024 ·
2m 3s
New research from the Primary Immune Deficiency Treatment Consortium (PIDTC). This summary is based on a paper published in the Journal of Allergy and Clinical Immunology on January 28, 2024,...
show more
New research from the Primary Immune Deficiency Treatment Consortium (PIDTC). This summary is based on a paper published in the Journal of Allergy and Clinical Immunology on January 28, 2024, titled "Allogeneic hematopoietic cell transplantation is effective for p47phox chronic granulomatous disease: A Primary Immune Deficiency Treatment Consortium study."
Read the paper here: https://www.jacionline.org/article/S0091-6749(24)00081-2/abstract
Learn more about PIDTC: https://pidtc.rarediseasesnetwork.org
show less
Read the paper here: https://www.jacionline.org/article/S0091-6749(24)00081-2/abstract
Learn more about PIDTC: https://pidtc.rarediseasesnetwork.org
Information
| Author | RDCRN |
| Website | - |
| Tags |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
